{"Title": "Best available evidence related to clinical benefit of surgical resection in multimodality treatment of metastatic colorectal cancer indicates that a randomised controlled trial is warranted.", "Year": 2017, "Source": "Eur. J. Cancer", "Volume": "75", "Issue": null, "Art.No": null, "PageStart": 310, "PageEnd": 312, "CitedBy": 0, "DOI": "10.1016/j.ejca.2016.11.033", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85013998825&origin=inward", "Abstract": null, "AuthorKeywords": null, "IndexKeywords": ["Colonic Neoplasms", "Colorectal Neoplasms", "Combined Modality Therapy", "Humans"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 2, "EID": "2-s2.0-85013998825", "SubjectAreas": [["Oncology", "MEDI", "2730"], ["Cancer Research", "BIOC", "1306"]], "AuthorData": {"57196678944": {"Name": "Treasure T.", "AuthorID": "57196678944", "AffiliationID": "60022148", "AffiliationName": "Clinical Operational Research Unit, University College London"}, "7402771456": {"Name": "Williams N.", "AuthorID": "7402771456", "AffiliationID": "60022148", "AffiliationName": "Surgical & Interventional Trials Unit, Division of Surgery & Interventional Science, University College London"}}}